Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT07055763

Effect Of Nigella Sativa Oil for the Treatment of Hypertension

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Superior University · Academic / Other
Sex
All
Age
30 Years – 70 Years
Healthy volunteers
Not accepted

Summary

My research explores the antihypertensive effects of Nigella sativa (black seed) oil in managing high blood pressure. Hypertension is a growing global health concern, often insufficiently controlled by standard medications. Nigella sativa, known for its bioactive compound thymoquinone, possesses antioxidant, anti-inflammatory, and vasodilatory properties, making it a potential natural remedy for blood pressure regulation.

Conditions

Interventions

TypeNameDescription
COMBINATION_PRODUCTNigella sativa (black seed)Participants in Group 1 (intervention group) will receive Nigella sativa (black seed) oil at a dosage of 0.5 ml, administered orally twice daily-once before breakfast and once before bedtime-for a duration of 12 weeks. The oil, sourced from a standardized local supplier, is rich in thymoquinone, known for its antioxidant and vasodilatory properties. Blood pressure will be measured at baseline and biweekly intervals using a calibrated digital sphygmomanometer to monitor changes in systolic and diastolic values. Participants will also be monitored regularly for any adverse effects.

Timeline

Start date
2022-03-17
Primary completion
2025-09-01
Completion
2026-02-28
First posted
2025-07-09
Last updated
2025-07-09

Locations

1 site across 1 country: Pakistan

Source: ClinicalTrials.gov record NCT07055763. Inclusion in this directory is not an endorsement.